Volume 22 Number 10

This EuroPCR issue of EuroIntervention opens with a State-of-the-Art on the timing of transcatheter aortic valve implantation; we continue with a Debate on prasugrel vs ticagrelor in acute coronary syndromes; our 5 Original Research articles cover glucocorticoids for post-TAVI pacemaker prevention; the 30-day results of the DOUBLE-CHOICE trial; optical coherence tomography vs angiography in true left main coronary artery bifurcation lesions; ticagrelor versus clopidogrel with concurrent direct oral anticoagulants in acute coronary syndromes; clinical benefit of renal denervation at 3 years; we also have news from PCR in this issue; and more...

In this issue of EuroIntervention

Our EuroPCR edition with a State-of-the-Art on the timing of TAVI; glucocorticoids for post-TAVI pacemaker implantation prevention; the DOUBLE-CHOICE trial; OCT vs angiography in true LMCA bifurcation lesions; prasugrel vs ticagrelor in ACS; ticagrelor versus clopidogrel in ACS with direct oral anticoagulants; news from PCR; and more...

Capodanno D

free

Viewpoint

Full-on commitment to interventional cardiology – today and in the future

Prendergast B, Barbato E, Dumonteil N, Gilard M, Tchétché D, Cuisset T, Gonzalo N, of the PCR Board ob

10.4244/EIJ-E-26-00007

free

Debate

Prasugrel should be preferred over ticagrelor in acute coronary syndromes: pros and cons

Angiolillo D, Kastrati A, Frazzetto M, Valgimigli M

10.4244/EIJ-E-26-00004

free

State-of-the-art

Timing of transcatheter aortic valve implantation in patients with aortic stenosis

Craig N, Prendergast B, Newby D, Dweck M

10.4244/EIJ-D-25-00754

free

Original Research

Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial

Fuertes-Kenneally L, Torres-Mezcua F, Herrero-Brocal M, Quesada Rico J, Ferrer R, Ballester S, Rocamora J, Siscar P, Valencia J, Torres-Saura F, López Clemente D, Riquelme C, López Clemente J, Palencia T, Ortiz de Salazar C, Rubio A, De la Hoz Marañón L, Mateo Soler J, Martínez J, Ruiz-Nodar J

10.4244/EIJ-D-26-00032

Editorial comment

Inflammation after TAVI: an emerging therapeutic target?

Pilgrim T, Cozzi O

10.4244/EIJ-D-26-00452

free

Comparison of self-expanding transcatheter heart valves for aortic stenosis: the multicentre, randomised, controlled, non-inferiority DOUBLE-CHOICE trial

Feistritzer H, Lauten P, Rudolph T, Rudolph V, Geisler T, Massberg S, Adam M, Baldus S, Sossalla S, Joner M, Moellmann H, Wolf A, Kim W, Borger M, Noack T, Boening A, Bleiziffer S, Hohenstein S, Hoesler N, Buske M, Majunke N, Lankisch N, Roeder M, Desch S, Thiele H, Abdel-Wahab M, of the DOUBLE-CHOICE investigators o

10.4244/EIJ-D-26-00001

Editorial comment

An unnecessary farewell? Drawing "accurate" lessons from DOUBLE-CHOICE

Blankenberg S, Ludwig S

10.4244/EIJ-E-26-00008

free

Optical coherence tomography versus angiographic guidance in true unprotected left main bifurcation disease: an OCTOBER substudy

Holck E, Andreasen L, Neghabat O, Laanmets P, Mogensen L, Spratt J, Bennett J, Calic S, Walsh S, O’Kane P, Cockburn J, Henerah L, Chowdhary S, Grikis K, Lønborg J, Heighert M, Kische S, Christiansen E

10.4244/EIJ-D-25-01337

Ticagrelor versus clopidogrel in orally anticoagulated patients with acute coronary syndrome undergoing percutaneous coronary intervention

Emilsson O, Mohammad M, van der Pals J, Braun O, Angerås O, Jernberg T, Zhou M, von Koch S, Erlinge D, Koul S

10.4244/EIJ-D-25-01373

open access